Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Double-blind placebo-controlled trial of terlipressin in severe alcoholic hepatitis
2006-002837-19Phase 4Terminated
- Sponsor
- Derby Hospitals NHS Foundation Trust
- Start
- Feb 2007
- Modality
- Peptides
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in alcoholic hepatitis (AH) comparing Terlipressin with Placebo (2 arms). Primary endpoint: Change in Maddrey score at day 30. Started Feb 2007; status: terminated.
02
Drugs
terlipressin
03
Conditions
alcoholic hepatitis (AH)
Beyond the preview
Go deeper on 2006-002837-19.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-002837-19.